Have a personal or library account? Click to login
NSTEMI Guideline During the Covid-19 Pandemia, the Missing Piece What’s New in the 2020 ESC Practice Guidelines? Cover

NSTEMI Guideline During the Covid-19 Pandemia, the Missing Piece What’s New in the 2020 ESC Practice Guidelines?

Open Access
|Jul 2021

References

  1. 1. Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2020. doi: 10.1093/eurheartj/ehaa575.10.1093/eurheartj/ehaa575
  2. 2. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 2009;361(11):1045-57. doi: 10.1056/NEJMoa0904327. PubMed PMID: 19717846.10.1056/NEJMoa0904327
  3. 3. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 2007;357(20):2001-15. doi: 10.1056/NEJMoa0706482. PubMed PMID: 17982182.10.1056/NEJMoa0706482
  4. 4. Schüpke S, Neumann F-J, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, et al. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 2019;381(16):1524-34. doi: 10.1056/NEJMoa1908973. PubMed PMID: 31475799.10.1056/NEJMoa1908973
  5. 5. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. New England Journal of Medicine. 2014;371(23):2155-66. doi: 10.1056/NEJMoa1409312. PubMed PMID: 25399658.10.1056/NEJMoa1409312
  6. 6. Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. New England Journal of Medicine. 2015;372(19):1791-800. doi: 10.1056/NEJMoa1500857. PubMed PMID: 25773268.10.1056/NEJMoa1500857
  7. 7. Valgimigli M, Frigoli E, Leonardi S, Rothenbühler M, Gagnor A, Calabrò P, et al. Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes. New England Journal of Medicine. 2015;373(11):997-1009. doi: 10.1056/NEJMoa1507854. PubMed PMID: 26324049.10.1056/NEJMoa1507854
DOI: https://doi.org/10.2478/inmed-2021-0166 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 51 - 56
Published on: Jul 27, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Mădălina Badea, Ana-Maria Balahura, Daniela Bartoş, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.